Wynn Capital LLC Purchases 682 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

by · The Cerbat Gem

Wynn Capital LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 20.4% in the third quarter, HoldingsChannel reports. The fund owned 4,027 shares of the company’s stock after purchasing an additional 682 shares during the quarter. Wynn Capital LLC’s holdings in GE HealthCare Technologies were worth $378,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the stock. Pathway Financial Advisers LLC purchased a new position in shares of GE HealthCare Technologies in the 1st quarter worth $25,000. Fred Alger Management LLC bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $26,000. BNP Paribas purchased a new position in shares of GE HealthCare Technologies in the 1st quarter worth approximately $30,000. Rise Advisors LLC raised its holdings in GE HealthCare Technologies by 241.4% during the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after buying an additional 239 shares during the period. Finally, Riverview Trust Co bought a new stake in GE HealthCare Technologies in the first quarter worth $31,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $91.03 on Friday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The stock has a market capitalization of $41.55 billion, a price-to-earnings ratio of 26.62, a PEG ratio of 3.39 and a beta of 1.18. The firm’s 50 day simple moving average is $86.98 and its 200-day simple moving average is $83.39. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same period last year, the company posted $0.92 EPS. GE HealthCare Technologies’s quarterly revenue was up .5% compared to the same quarter last year. Analysts expect that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Wednesday, September 18th. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. Evercore ISI lifted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price objective for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Finally, Stifel Nicolaus lifted their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.23.

View Our Latest Research Report on GEHC

Insider Activity

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Further Reading

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).